Blood test for genetic changes in brain vessel malformations
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at whether a simple blood test (called a 'liquid biopsy') can find specific genetic changes in people with cerebral arteriovenous malformations. It aims to help doctors better understand and possibly manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a cerebral arteriovenous malformation (an abnormal tangle of blood vessels in the brain)
- You are scheduled to have embolisation (a procedure that blocks the abnormal vessels), and this decision was made by a team of specialists
- You are willing to take part in the study and have been told what it involves
- You are not pregnant and are not under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain arteriovenous malformations (abnormal connections between arteries and veins in the brain) behave over time, and how different treatment choices affect outcomes. It may help researchers better predict prognosis and guide future care.
This trial uses a blood test to look for genetic mutations in brain arteriovenous malformations (bAVMs). It may help doctors understand these lesions better and guide treatment.
This study looks at genetic (inherited DNA) factors in people with certain abnormal blood vessel connections in the brain or spinal cord. It may help researchers understand why these malformations happen and how they might behave over time.
This study checks people long-term after a procedure called embolization, which blocks abnormal blood vessel connections in the brain (arteriovenous malformations). It may help doctors learn how well the treatment lasts over time and what outcomes to expect.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
This study collects medical and imaging information from people with a brain arteriovenous malformation (AVM) to understand how different treatments are used in real life. It may help doctors improve future care, even if you are not receiving a new drug in this study.
Hear when a new Cerebral Arteriovenous Malformations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.